Vicki Sifniotis

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 2

Top Topics

Epidermal Growth Factor Receptor

Juvenile Idiopathic Arthritis

Top Venues

Antibodies (Basel, Switzerland)

The University of Sydney (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

The University of Sydney - Jun 17 2019

Australia

PHD :: School of Pharmacy, Faculty of Medicine and Health

Publications

Esteban Cruz, Vicki Sifniotis, Zeynep Sumer-Bayraktar, Mouhamad Reslan, Lorna Wilkinson-White, Stuart Cordwell, Veysel Kayser
Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity. Pharmaceutics 13 (11) (2021)
Vicki Sifniotis, Esteban Cruz, Barbaros Eroglu, Veysel Kayser
Current Advancements in Addressing Key Challenges of Therapeutic Antibody Design, Manufacture, and Formulation. Antibodies (Basel, Switzerland) 8 (2) (2019)